Peak flow rate is the best predictor of acute urinary retention following prostate brachytherapy

International Journal of Urology

Volumn 16, Issue 6, 2009, Pages 558-560

  Ikeda, Tetsuhiro ^a,b   Shinohara, Katsuto ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EHIME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute urinary retention; Peak Flow Rate; Prostate brachytherapy

Indexed keywords

IODINE 125; PALLADIUM 103;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER STAGING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RESIDUAL URINE; RISK FACTOR; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY; URETHRAL CATHETERIZATION; URINE FLOW RATE; URINE RETENTION;

ACUTE DISEASE; AGED; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RISK FACTORS; URINARY RETENTION;

EID: 66949135438     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02303.x     Document Type: Article

References (12)

1. Holm HH, Jull JF, Pedersen H et al. Transperineal i-125 seed implantation in prostatic cancer guided by transrectal ultrasonography. J. Urol. 1983 130 : 283 5.
2. Ragde H, Elgamal AA, Snow PB et al. Ten year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998 83 : 989 1001. (Pubitemid 28401934)
3. Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal I-125 implantation for stage T1/T2 prostate carcinoma. J. Clin. Oncl. 1996 14 : 449 53.
4. Merrick GS, Butler WM, Dorsey AT et al. Rectal dosimetric analysis following prostate brachytherapy. Int. J. Radiat. Oncl. Biol. Phys. 1999 43 : 1021 7.
5. Merrick GS, Butler WM, Lief JH et al. Temporal resolution of urinary morbidity following prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000 47 : 121 8.
6. Lee N, Wuu CS, Brondy R et al. Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000 48 : 1457 60.
7. Thomas MD, Cormack R, Tempany CM et al. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000 47 : 905 8.
8. Locke J, Ellis W, Wallner K et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: A prospective study. Int. J. Radiat. Oncol. Biol. Phys. 2002 52 : 712 19.
9. Crook J, McLean M, Catton C et al. Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. Int. J. Radiat. Oncol. Biol. Phys. 2002 52 : 453 60.
10. Elshaikh MA, Angermeier K, Ulchaker JC et al. Effect of anatomic, procedural, and domestic variables on urinary retention after permanent Iodine-125 prostate brachytherapy. Urology 2003 61 : 152 5.
11. Williams SG, Millar JL, Duchesne GM et al. Factors predicting for urinary morbidity following 125 iodine transperineal prostate brachytherapy. Radiat. Oncol. 2004 73 : 33 8.
12. Martens C, Pond G, Webster D et al. Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125-I prostate brachytherapy. Brachytherapy 2006 5 : 9 13.